🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our CEO and members of the NIMBLE Diagnostics team recently took a trip to #LasVegas to participate in the Mobile World Capital. Here we were able to demonstrate to our stakeholders the significant progress in our quest to make early #cardiovascular diagnosis accessible to all.

We are thrilled to announce that NIMBLE Diagnostics has been awarded the Best Innovation of 2023 by the #SITESymposium. This award reinforces our commitment to continue working tirelessly to bring novel technology to #cardiovascular #patients.

#Stents are remarkable medical devices that save lives every day. But, like any medical intervention, they aren't without their challenges. Check out this #article that walks us through the signs of stent failure that patients should be aware of. dxnimble.com/symptoms-of-a-…

Coronary #stent monitoring can be a complex issue, and understanding the importance of following up with your #clinician can lead to better clinical outcomes. Below we discuss specific guidelines for how to monitor a stent after placement. #NIMBLE dxnimble.com/how-long-to-mo…

The #recovery process after a heart attack can vary from person to person; however, with proper #lifestyle changes and medical care, many individuals can lead a healthy life. dxnimble.com/recovery-after… #heartattack #stent #stents #recovery #lifestyle #hearthealthy

After the introduction of #coronary stents, many #patients improved their quality of life after a #heart attack, but the journey doesn’t end there. Post-operative care is crucial to maximize the stent’s lifespan. Click the article below to learn more. dxnimble.com/post-coronary-…

Round of applause for the newest #eicAccelerator companies! 👏 🚀 47 companies from 🌍 15 countries are set to receive 💰 €349 million Learn more about them and their game-changing #innovations here ➡️ europa.eu/!wCbjVK

NIMBLE Diagnostics is proud to announce that we have been #awarded the #EIC Accelerator grant in our very first submission, securing a non-dilutive compensation of €2.5 million. This recognition is one of the highest honors given by the European Commission to #MedTech startups!

🎉 Enhorabuena a las 47 empresas seleccionadas en el último corte de la convocatoria del #Acelerador del European Innovation Council #HorizonteEuropa. 🇪🇸 Y especialmente a las 3 empresas españolas que han conseguido financiación PEPTOMYC NIMBLE Diagnostics Quside 👏👏

We are thrilled to be selected!

We are proud to announce that we have been accepted to take part in Barcelona Deep Tech Summit which takes place on the 28th and 29th of November 2023. We have been accepted to take part in the Start-Up Pitches Agenda and to have an exhibition booth!

We are excited to participate in the 4YFN taking place from February 26th to the 29th. This event is in partnership with the MWC Barcelona, one of the world's largest and most influential connectivity events, and you can find us within the Startup Corner UPC! #startups

Join NIMBLE Diagnostics on November 29th at the Barcelona Deep Tech Summit roundtable titled: ‘From 0 to 1: How to build a company from a PhD’. You can find our CTO, Susana Amorós, speaking about her experiences of building a #startup, like NIMBLE Diagnostics, in the main auditorium at 12:00.

This article walks through the significance of #angiography and explores alternative methods that can determine whether a patient is experiencing coronary artery disease or #stent failure. dxnimble.com/diagnosis-of-c…

This past weekend, our CEO had the opportunity to present at the BCNspiracy event, where he discussed the future of #Medical implants and how NIMBLE Diagnostics will play a vital role in #patient #diagnostics for millions. #MEDTECH

Our Chief Technology Officer, Susana Amorós, has been honored with an award for the best spin-off during the 25th-anniversary celebration hosted by Universitat Politècnica de Catalunya (UPC) . We are extremely proud to receive this recognition and excited to continue to grow and develop the NIMBLE system.

Our Chief Technology Officer, Susana Amorós, has been honored with an #award for the best spin-off during the 25th-anniversary celebration hosted by Universitat Politècnica de Catalunya (UPC). We are extremely proud to receive this #recognition and excited to continue to grow and develop the NIMBLE system.#MedTech